The store will not work correctly when cookies are disabled.
US9162991, 4h
ID: ALA3931451
PubChem CID: 25053517
Max Phase: Preclinical
Molecular Formula: C18H13N5O5
Molecular Weight: 379.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(/C=C/c1ccc([N+](=O)[O-])cc1)c1cn(Cc2cccc([N+](=O)[O-])c2)nn1
Standard InChI: InChI=1S/C18H13N5O5/c24-18(9-6-13-4-7-15(8-5-13)22(25)26)17-12-21(20-19-17)11-14-2-1-3-16(10-14)23(27)28/h1-10,12H,11H2/b9-6+
Standard InChI Key: ALVRGEGYRAZIRZ-RMKNXTFCSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5956 -2.7031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8056 -3.8680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3371 -5.2929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8371 -5.2877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3786 -3.8595 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2110 -6.5099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4051 -6.3907 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5938 -7.8780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4693 -9.0970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8521 -10.4651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7252 -11.6848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1056 -13.0508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6128 -13.1973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7396 -11.9776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3592 -10.6116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9900 -14.5628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7956 -14.6782 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6869 -15.5397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 10 1 0
12 15 1 0
15 16 2 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
25 26 1 0
25 27 2 0
8 28 2 0
28 4 1 0
M CHG 4 1 -1 2 1 25 1 26 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 379.33 | Molecular Weight (Monoisotopic): 379.0917 | AlogP: 3.04 | #Rotatable Bonds: 7 |
Polar Surface Area: 134.06 | Molecular Species: NEUTRAL | HBA: 8 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 10 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.93 | CX LogD: 3.93 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.27 | Np Likeness Score: -1.58 |
References
1. (2015) Cinnamoyl inhibitors of transglutaminase, |